Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Nutra Pharma's shares outstanding was 8.07B at Jun 30, 2026. For fiscal 2025 it was 7.78B, up 1.4% from the year before. Over ten years it grew 63.9% a year on average. The highest annual figure on record is 19.10B in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.78B | +1.4% |
| FY2024 | Dec 31, 2024 | 7.67B | +0.9% |
| FY2023 | Dec 31, 2023 | 7.61B | -60.2% |
| FY2022 | Dec 31, 2022 | 19.10B | +164.0% |
| FY2021 | Dec 31, 2021 | 7.23B | +9.5% |
| FY2020 | Dec 31, 2020 | 6.61B | +40.3% |
| FY2019 | Dec 31, 2019 | 4.71B | +47.8% |
| FY2018 | Dec 31, 2018 | 3.19B | +204.0% |
| FY2017 | Dec 31, 2017 | 1.05B | +522.3% |
| FY2016 | Dec 31, 2016 | 168M | +203.0% |
| FY2015 | Dec 31, 2015 | 56M | +81.4% |
| FY2014 | Dec 31, 2014 | 31M | +64.9% |
| FY2013 | Dec 31, 2013 | 19M | +84.5% |
| FY2012 | Dec 31, 2012 | 10M | +35.4% |
| FY2011 | Dec 31, 2011 | 7M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 8.07B | -78.6% |
| Q1 FY2026 | Mar 31, 2026 | 8.01B | +4.4% |
| Q4 FY2025 | Dec 31, 2025 | 7.88B | +1.8% |
| Q3 FY2025 | Sep 30, 2025 | 7.82B | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | 37.73B | +392.7% |
| Q1 FY2025 | Mar 31, 2025 | 7.68B | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | 7.74B | +1.5% |
| Q3 FY2024 | Sep 30, 2024 | 7.66B | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | 7.66B | +0.8% |
| Q1 FY2024 | Mar 31, 2024 | 7.64B | +0.6% |
| Q4 FY2023 | Dec 31, 2023 | 7.62B | -75.5% |
| Q3 FY2023 | Sep 30, 2023 | 7.61B | -51.2% |
| Q2 FY2023 | Jun 30, 2023 | 7.60B | +1.7% |
| Q1 FY2023 | Mar 31, 2023 | 7.60B | -47.6% |
| Q4 FY2022 | Dec 31, 2022 | 31.07B | +324.1% |
| Q3 FY2022 | Sep 30, 2022 | 15.60B | +23.1% |
| Q2 FY2022 | Jun 30, 2022 | 7.47B | -36.5% |
| Q1 FY2022 | Mar 31, 2022 | 14.50B | +105.2% |
| Q4 FY2021 | Dec 31, 2021 | 7.33B | +6.3% |
| Q3 FY2021 | Sep 30, 2021 | 12.67B | -3.1% |
| Q2 FY2021 | Jun 30, 2021 | 11.76B | +77.6% |
| Q1 FY2021 | Mar 31, 2021 | 7.06B | -42.5% |
| Q4 FY2020 | Dec 31, 2020 | 6.89B | +34.8% |
| Q3 FY2020 | Sep 30, 2020 | 13.08B | +158.5% |
| Q2 FY2020 | Jun 30, 2020 | 6.62B | +43.6% |
| Q1 FY2020 | Mar 31, 2020 | 12.29B | +198.9% |
| Q4 FY2019 | Dec 31, 2019 | 5.11B | +24.4% |
| Q3 FY2019 | Sep 30, 2019 | 5.06B | +36.4% |
| Q2 FY2019 | Jun 30, 2019 | 4.61B | +69.4% |
| Q1 FY2019 | Mar 31, 2019 | 4.11B | +87.9% |
| Q4 FY2018 | Dec 31, 2018 | 4.11B | +1186.3% |
| Q3 FY2018 | Sep 30, 2018 | 3.71B | +3105.7% |
| Q2 FY2018 | Jun 30, 2018 | 2.72B | +2895.3% |
| Q1 FY2018 | Mar 31, 2018 | 2.19B | – |
| Q1 FY2017 | Mar 31, 2017 | 319M | – |
| Q2 FY2016 | Jun 30, 2016 | 116M | – |
| Q1 FY2016 | Mar 31, 2016 | 91M | – |
See a number that looks wrong?